ROIV 株価推移チャート
ROIV 株価予測
Roivant Sciences Ltd
$28.69
1.48%
$0.42
終値： Jun 03, 16:00:00 GMT-4
$28.7
0.03%
$0
アフターマーケット：Jun 03, 20:00:00 GMT-4
戻る
Roivant Sciences Ltd (ROIV) 株価予測
主要データ
前終値
$28.27
始値
$28.29
当日レンジ
$28.22 - $28.8
52週レンジ
$10.58 - $30.33
取引高
3.4M
平均取引高
5.8M
配当利回り
--
1株当たり利益(TTM)
-1.17
時価総額
$20.5B
ROIVとは何ですか？
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
